(Q45240686)

11 December 2017

1 reference

title

Atrial fibrillation and thromboprophylaxis in elderly patients (English)

1 reference

11 December 2017

1 reference

2

1 reference

11 December 2017

I Jörg

1

1 reference

11 December 2017

T Fenyvesi

series ordinal

3

1 reference

11 December 2017

R Gladisch

series ordinal

4

1 reference

11 December 2017

language of work or name

German

0 references

publication date

1 February 2005

1 reference

Clinical Research in Cardiology

11 December 2017

published in

1 reference

11 December 2017

volume

94

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

87-94

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-005-0172-y

11 December 2017

exact match

0 references

cites work

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1007%2FS00392-005-0172-Y

Risk factors for intracranial hemorrhage in outpatients taking warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-005-0172-Y

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-005-0172-Y

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-005-0172-Y

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

21 January 2018

1 reference

12 December 2020

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

12 December 2020

Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers

1 reference

12 December 2020

Atrial fibrillation: the epidemic of the new millennium

1 reference

12 December 2020

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

12 December 2020

Anticoagulation of older patients.

1 reference

12 December 2020

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

12 December 2020

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

12 December 2020

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

12 December 2020

Hemorrhagic complications of anticoagulant treatment

1 reference

12 December 2020

Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation

1 reference

12 December 2020

Antithrombotic therapy in atrial fibrillation

1 reference

12 December 2020

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

1 reference

12 December 2020

Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study

1 reference

12 December 2020

Drug-induced hepatitis: a rare complication of oral anticoagulants

1 reference

12 December 2020

A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial

1 reference

12 December 2020

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

1 reference

12 December 2020

The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials

1 reference

12 December 2020

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

1 reference

12 December 2020

A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

1 reference

12 December 2020

Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion

1 reference

12 December 2020

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

12 December 2020

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

12 December 2020

Heparin-induced increase in serum levels of aminotranferases. A controlled clinical trial

1 reference

12 December 2020

The effect of self-monitoring the INR on quality of anticoagulation and quality of life.

1 reference

12 December 2020

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

1 reference

12 December 2020

Prophylaxis of embolic events in patients with atrial fibrillation using low molecular weight heparin

1 reference

12 December 2020

[Antithrombotic therapy in atrial fibrillation and additional stroke/embolism risk factors. CORSurvey Study]

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK)

1 reference

12 December 2020

Effects of lepirudin, argatroban and melagatran and additional influence of phenprocoumon on ecarin clotting time

1 reference

12 December 2020

10.1007/S00392-005-0172-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1041350902

0 references

1 reference